Journal of Southern Medical University ›› 2025, Vol. 45 ›› Issue (5): 995-1002.doi: 10.12122/j.issn.1673-4254.2025.05.12
Previous Articles Next Articles
Yueying DENG1(), Yawen GENG1, Tingting PENG2, Junchao QIU3, Lijuan HE4, Dan XIE2, Ziren CHEN2, Shi OUYANG1,2(
), Shengguang YAN1,5,6(
)
Received:
2025-01-15
Online:
2025-05-20
Published:
2025-05-23
Contact:
Shi OUYANG, Shengguang YAN
E-mail:1014564621@qq.com;ouyangshi@gzhmu.edu.cn;yansg@ncst.edu.cn
Yueying DENG, Yawen GENG, Tingting PENG, Junchao QIU, Lijuan HE, Dan XIE, Ziren CHEN, Shi OUYANG, Shengguang YAN. Chronic HBV infection affects health-related quality of life in pregnant women in the second and third trimesters and postpartum period: a prospective cohort study[J]. Journal of Southern Medical University, 2025, 45(5): 995-1002.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.j-smu.com/EN/10.12122/j.issn.1673-4254.2025.05.12
Variables | All mothers | HBV-infected mothers | Healthy mothers | t | P |
---|---|---|---|---|---|
(n=140) | (n=70) | (n=70) | |||
Mean age (SD, year) | 29.59±3.4 | 30.30±3.99 | 29.34±3.08 | 2.97 | 0.09 |
<30 | 72 (51.4) | 31 (44.3) | 41 (58.6) | 2.86 | 0.09 |
≥30 | 68 (48.6) | 39 (55.7) | 29 (41.4) | ||
Living conditions | 2.21 | 0.7 | |||
Very dissatisfied | 3 (2.1) | 1 (1.4) | 2 (2.8) | ||
Less Satisfied | 3 (2.1) | 1 (1.4) | 2 (2.8) | ||
Fair | 17 (12.1) | 11 (15.7) | 6 (8.6) | ||
More Satisfied | 41 (29.3) | 20 (28.6) | 21 (30) | ||
Most Satisfied | 76 (54.3) | 37 (52.9) | 39 (55.7) | ||
Payment method | 0.1 | 0.61 | |||
Public insurance | 3 (2.1) | 2 (2.8) | 1 (1.4) | ||
Medical insurance | 120 (85.7) | 58 (82.9) | 62 (88.6) | ||
Self-pay | 17 (12.1) | 10 (14.3) | 7 (10) | ||
Family atmosphere | 3.82 | 0.15 | |||
Fair | 9 (6.4) | 7(10) | 2 (2.8) | ||
Better | 59 (42.1) | 31 (44.3) | 28 (40) | ||
Excellent | 72 (51.4) | 32 (45.7) | 40 (57.1) | ||
As a caregiver to a patient in the family | 1.07 | 0.3 | |||
No | 131 (93.6) | 64 (91.4) | 67 (95.7) | ||
Yes | 9 (6.3) | 6 (8.6) | 3 (4.2) | ||
Working full time | 0 | 1 | |||
No | 42 (30) | 21 (30) | 21 (30) | ||
Yes | 98 (70) | 49 (70) | 49 (70) | ||
Family support | 1.87 | 0.17 | |||
No | 5 (3.6) | 4 (5.7) | 1 (1.4) | ||
Yes | 135 (96.4) | 66 (94.3) | 69 (98.6) | ||
First-born or not | |||||
No | 52 (37.1) | 21 (30) | 31 (44.3) | 3.06 | 0.08 |
Yes | 88 (62.9) | 49 (70) | 39 (55.7) | ||
Planned pregnancy | 1.26 | 0.262 | |||
No | 40 (28.6) | 17 (24.3) | 43 (61.4) | ||
Yes | 100 (71.4) | 53 (75.7) | 47 (67.1) | ||
Spouse's attitude | 2.03 | 0.363 | |||
Oppose | 1 (2.1) | 1 (1.4) | 0 (0) | ||
Support | 138 (98.6) | 68 (97.1) | 70 (100) | ||
Neutral | 1 (2.1) | 1 (1.4) | 0 (0) | ||
Nausea and vomiting in pregnancy | 3.7 | 0.3 | |||
No | 18 (12.9) | 12 (17.1) | 6 (8.6) | ||
Mild | 50 (35.7) | 24 (34.3) | 26 (37.1) | ||
Moderate | 61 (43.6) | 27 (38.6) | 34 (48.6) | ||
Severe | 11 (7.9) | 7 (10) | 4 (5.6) | ||
Other diseases before pregnancy | 0.49 | 0.17 | |||
No | 121 (83.4) | 62 (88.6) | 59 (84.3) | ||
Yes | 19 (13.6) | 8 (11.4) | 11 (15.7) | ||
complications of pregnancy | 0.15 | 0.7 | |||
No | 36 (25.7) | 47 (67.1) | 19 (27.1) | ||
Yes | 104 (74.3) | 53 (75.7) | 51 (72.9) | ||
HBeAg positive | 23 (32.9) | ||||
Antiviral treatment | 25 (35.7) | ||||
Family member infected with HBV | 33 (47.1) | ||||
HBV DNA≥2×100 000 IU/mL | 19 (21.7) |
Tab.1 Demographic and clinical parameters of the participants
Variables | All mothers | HBV-infected mothers | Healthy mothers | t | P |
---|---|---|---|---|---|
(n=140) | (n=70) | (n=70) | |||
Mean age (SD, year) | 29.59±3.4 | 30.30±3.99 | 29.34±3.08 | 2.97 | 0.09 |
<30 | 72 (51.4) | 31 (44.3) | 41 (58.6) | 2.86 | 0.09 |
≥30 | 68 (48.6) | 39 (55.7) | 29 (41.4) | ||
Living conditions | 2.21 | 0.7 | |||
Very dissatisfied | 3 (2.1) | 1 (1.4) | 2 (2.8) | ||
Less Satisfied | 3 (2.1) | 1 (1.4) | 2 (2.8) | ||
Fair | 17 (12.1) | 11 (15.7) | 6 (8.6) | ||
More Satisfied | 41 (29.3) | 20 (28.6) | 21 (30) | ||
Most Satisfied | 76 (54.3) | 37 (52.9) | 39 (55.7) | ||
Payment method | 0.1 | 0.61 | |||
Public insurance | 3 (2.1) | 2 (2.8) | 1 (1.4) | ||
Medical insurance | 120 (85.7) | 58 (82.9) | 62 (88.6) | ||
Self-pay | 17 (12.1) | 10 (14.3) | 7 (10) | ||
Family atmosphere | 3.82 | 0.15 | |||
Fair | 9 (6.4) | 7(10) | 2 (2.8) | ||
Better | 59 (42.1) | 31 (44.3) | 28 (40) | ||
Excellent | 72 (51.4) | 32 (45.7) | 40 (57.1) | ||
As a caregiver to a patient in the family | 1.07 | 0.3 | |||
No | 131 (93.6) | 64 (91.4) | 67 (95.7) | ||
Yes | 9 (6.3) | 6 (8.6) | 3 (4.2) | ||
Working full time | 0 | 1 | |||
No | 42 (30) | 21 (30) | 21 (30) | ||
Yes | 98 (70) | 49 (70) | 49 (70) | ||
Family support | 1.87 | 0.17 | |||
No | 5 (3.6) | 4 (5.7) | 1 (1.4) | ||
Yes | 135 (96.4) | 66 (94.3) | 69 (98.6) | ||
First-born or not | |||||
No | 52 (37.1) | 21 (30) | 31 (44.3) | 3.06 | 0.08 |
Yes | 88 (62.9) | 49 (70) | 39 (55.7) | ||
Planned pregnancy | 1.26 | 0.262 | |||
No | 40 (28.6) | 17 (24.3) | 43 (61.4) | ||
Yes | 100 (71.4) | 53 (75.7) | 47 (67.1) | ||
Spouse's attitude | 2.03 | 0.363 | |||
Oppose | 1 (2.1) | 1 (1.4) | 0 (0) | ||
Support | 138 (98.6) | 68 (97.1) | 70 (100) | ||
Neutral | 1 (2.1) | 1 (1.4) | 0 (0) | ||
Nausea and vomiting in pregnancy | 3.7 | 0.3 | |||
No | 18 (12.9) | 12 (17.1) | 6 (8.6) | ||
Mild | 50 (35.7) | 24 (34.3) | 26 (37.1) | ||
Moderate | 61 (43.6) | 27 (38.6) | 34 (48.6) | ||
Severe | 11 (7.9) | 7 (10) | 4 (5.6) | ||
Other diseases before pregnancy | 0.49 | 0.17 | |||
No | 121 (83.4) | 62 (88.6) | 59 (84.3) | ||
Yes | 19 (13.6) | 8 (11.4) | 11 (15.7) | ||
complications of pregnancy | 0.15 | 0.7 | |||
No | 36 (25.7) | 47 (67.1) | 19 (27.1) | ||
Yes | 104 (74.3) | 53 (75.7) | 51 (72.9) | ||
HBeAg positive | 23 (32.9) | ||||
Antiviral treatment | 25 (35.7) | ||||
Family member infected with HBV | 33 (47.1) | ||||
HBV DNA≥2×100 000 IU/mL | 19 (21.7) |
Dimensions | Intervals | HBV-infected mothers Healthy mothers | t | P | |
---|---|---|---|---|---|
PF | 16-24 weeks gestation | 88.29±8.88 | 89.36±6.37 | 0.82 | 0.41 |
32 weeks gestation-Delivery | 77.68±12.94 | 83.07±8.61 | 2.9 | 0.004 | |
5-13 weeks postpartum | 88.48±10.89 | 93.52±5.87 | 3.23 | 0.002 | |
RP | 16-24 weeks gestation | 80.00±32.02 | 83.57±29.45 | 0.69 | 0.49 |
32 weeks gestation-Delivery | 67.03±36.76 | 73.57±35.07 | 1.074 | 0.29 | |
5-13 weeks postpartum | 67.75±34.06 | 80.33±27.43 | 2.3 | 0.02 | |
BP | 16-24 weeks gestation | 90.23±17.57 | 87.71±16.12 | -0.88 | 0.38 |
32 weeks gestation-Delivery | 79.12±21.31 | 80.46±17.72 | 0.4 | 0.69 | |
5-13 weeks postpartum | 79.03±20.41 | 82.3±15.77 | 1.01 | 0.31 | |
GH | 16-24 weeks gestation | 73.81±15.2 | 76.01±14.45 | 0.878 | 0.38 |
32 weeks gestation-Delivery | 73.43±14.45 | 79.12±21.31 | 1.03 | 0.3 | |
5-13 weeks postpartum | 73.43±14.97 | 76.49±13.81 | 1.24 | 0.22 | |
PCS | 16-24 weeks gestation | 83.08±13.46 | 84.25±11.01 | 0.56 | 0.57 |
32 weeks gestation-Delivery | 74.32±16.16 | 78.28±14.74 | 1.51 | 0.13 | |
5-13 weeks postpartum | 77.17±14.71 | 83.09±10.1 | 2.64 | 0.01 |
Tab.2 Mean scores for different dimensions of PCS of the two groups (Mean±SD)
Dimensions | Intervals | HBV-infected mothers Healthy mothers | t | P | |
---|---|---|---|---|---|
PF | 16-24 weeks gestation | 88.29±8.88 | 89.36±6.37 | 0.82 | 0.41 |
32 weeks gestation-Delivery | 77.68±12.94 | 83.07±8.61 | 2.9 | 0.004 | |
5-13 weeks postpartum | 88.48±10.89 | 93.52±5.87 | 3.23 | 0.002 | |
RP | 16-24 weeks gestation | 80.00±32.02 | 83.57±29.45 | 0.69 | 0.49 |
32 weeks gestation-Delivery | 67.03±36.76 | 73.57±35.07 | 1.074 | 0.29 | |
5-13 weeks postpartum | 67.75±34.06 | 80.33±27.43 | 2.3 | 0.02 | |
BP | 16-24 weeks gestation | 90.23±17.57 | 87.71±16.12 | -0.88 | 0.38 |
32 weeks gestation-Delivery | 79.12±21.31 | 80.46±17.72 | 0.4 | 0.69 | |
5-13 weeks postpartum | 79.03±20.41 | 82.3±15.77 | 1.01 | 0.31 | |
GH | 16-24 weeks gestation | 73.81±15.2 | 76.01±14.45 | 0.878 | 0.38 |
32 weeks gestation-Delivery | 73.43±14.45 | 79.12±21.31 | 1.03 | 0.3 | |
5-13 weeks postpartum | 73.43±14.97 | 76.49±13.81 | 1.24 | 0.22 | |
PCS | 16-24 weeks gestation | 83.08±13.46 | 84.25±11.01 | 0.56 | 0.57 |
32 weeks gestation-Delivery | 74.32±16.16 | 78.28±14.74 | 1.51 | 0.13 | |
5-13 weeks postpartum | 77.17±14.71 | 83.09±10.1 | 2.64 | 0.01 |
Dimensions | Intervals | HBV-infected mothers Healthy mothers | t | P | |
---|---|---|---|---|---|
VT | 16-24 weeks gestation | 68.86±15.3 | 72.57±15.48 | 1.43 | 0.16 |
32 weeks gestation-Delivery | 67.46±12.45 | 70.93±12.52 | 1.636 | 0.1 | |
5-13 weeks postpartum | 66.5±15.98 | 72.28±11.54 | 2.34 | 0.02 | |
SF | 16-24 weeks gestation | 92.38±16.11 | 95.87±9.86 | 1.55 | 0.12 |
32 weeks gestation-Delivery | 89.13±15.16 | 91.9±15.47 | 1.07 | 0.29 | |
5-13 weeks postpartum | 88.29±15.61 | 97.17±6.52 | 4.14 | <0.001 | |
RE | 16-24 weeks gestation | 82.83±29.88 | 88.57±26.55 | 1.2 | 0.23 |
32 weeks gestation-Delivery | 68.07±34.48 | 84.27±25.83 | 3.14 | 0.002 | |
5-13 weeks postpartum | 77.58±33.9 | 96.15±12.31 | 4.05 | <0.001 | |
MH | 16-24 weeks gestation | 72.91±16 | 72.86±13.27 | -0.2 | 0.98 |
32 weeks gestation-Delivery | 72.41±13.76 | 73.71±12.08 | 0.6 | 0.55 | |
5-13 weeks postpartum | 73.71±13.85 | 74.49±9.04 | 0.37 | 0.71 | |
MCS | 16-24 weeks gestation | 79.27±13.93 | 82.47±11.3 | 1.49 | 0.14 |
32 weeks gestation-Delivery | 74.27±13.43 | 80.21±12.9 | 2.67 | 0.01 | |
5-13 weeks postpartum | 76.52±16.19 | 85.02±6.51 | 3.84 | <0.001 |
Tab.3 Mean scores of for different dimensions of MCS in the two groups (Mean±SD)
Dimensions | Intervals | HBV-infected mothers Healthy mothers | t | P | |
---|---|---|---|---|---|
VT | 16-24 weeks gestation | 68.86±15.3 | 72.57±15.48 | 1.43 | 0.16 |
32 weeks gestation-Delivery | 67.46±12.45 | 70.93±12.52 | 1.636 | 0.1 | |
5-13 weeks postpartum | 66.5±15.98 | 72.28±11.54 | 2.34 | 0.02 | |
SF | 16-24 weeks gestation | 92.38±16.11 | 95.87±9.86 | 1.55 | 0.12 |
32 weeks gestation-Delivery | 89.13±15.16 | 91.9±15.47 | 1.07 | 0.29 | |
5-13 weeks postpartum | 88.29±15.61 | 97.17±6.52 | 4.14 | <0.001 | |
RE | 16-24 weeks gestation | 82.83±29.88 | 88.57±26.55 | 1.2 | 0.23 |
32 weeks gestation-Delivery | 68.07±34.48 | 84.27±25.83 | 3.14 | 0.002 | |
5-13 weeks postpartum | 77.58±33.9 | 96.15±12.31 | 4.05 | <0.001 | |
MH | 16-24 weeks gestation | 72.91±16 | 72.86±13.27 | -0.2 | 0.98 |
32 weeks gestation-Delivery | 72.41±13.76 | 73.71±12.08 | 0.6 | 0.55 | |
5-13 weeks postpartum | 73.71±13.85 | 74.49±9.04 | 0.37 | 0.71 | |
MCS | 16-24 weeks gestation | 79.27±13.93 | 82.47±11.3 | 1.49 | 0.14 |
32 weeks gestation-Delivery | 74.27±13.43 | 80.21±12.9 | 2.67 | 0.01 | |
5-13 weeks postpartum | 76.52±16.19 | 85.02±6.51 | 3.84 | <0.001 |
Group | 16-24 weeks gestation | 32 weeks gestation-Delivery | 5-13 weeks postpartum | F | P |
---|---|---|---|---|---|
SF-36:MCS | |||||
HBV-infected mothers | 79.27±13.93 | 74.27±13.43 | 76.52±16.19 | 3.86 | 0.23 |
Healthy mothers | 82.47±11.3 | 80.21±12.9 | 85.02±6.51 | 6.97 | <0.01 |
t | 1.49 | 2.67 | 3.84 | ||
P | 0.14 | 0.01 | <0.001 | ||
SF-36:PCS | |||||
HBV-infected mothers | 83.08±13.46 | 74.32±16.16 | 77.17±14.71 | 11.7 | <0.01 |
Healthy mothers | 84.25±11.01 | 78.28±14.74 | 83.09±10.1 | 12.68 | <0.01 |
t | 0.56 | 1.51 | 2.64 | ||
P | 0.57 | 0.13 | 0.01 |
Tab.4 Comparison of HRQoL during pregnancy and postpartum between HBV-infected and healthy pregnant women
Group | 16-24 weeks gestation | 32 weeks gestation-Delivery | 5-13 weeks postpartum | F | P |
---|---|---|---|---|---|
SF-36:MCS | |||||
HBV-infected mothers | 79.27±13.93 | 74.27±13.43 | 76.52±16.19 | 3.86 | 0.23 |
Healthy mothers | 82.47±11.3 | 80.21±12.9 | 85.02±6.51 | 6.97 | <0.01 |
t | 1.49 | 2.67 | 3.84 | ||
P | 0.14 | 0.01 | <0.001 | ||
SF-36:PCS | |||||
HBV-infected mothers | 83.08±13.46 | 74.32±16.16 | 77.17±14.71 | 11.7 | <0.01 |
Healthy mothers | 84.25±11.01 | 78.28±14.74 | 83.09±10.1 | 12.68 | <0.01 |
t | 0.56 | 1.51 | 2.64 | ||
P | 0.57 | 0.13 | 0.01 |
Dimensions | Variables | β | Standard Error | t | P | 95% CI |
---|---|---|---|---|---|---|
MCS (32 weeks gestation-Delivery) | Working full time | -0.6 | 2.43 | -0.25 | 0.81 | -5.41, 4.21 |
HBV infected | -5.94 | 2.23 | -2.66 | 0.01 | -10.35, 1.53 | |
MCS (5-13 weeks postpartum) | Payment method=Public insurance | -6.43 | 6.91 | -0.93 | 0.35 | -20.11, 7.24 |
Payment method=Self-pay | -8 | 3.12 | -2.56 | 0.01 | -14.17, -1.82 | |
Family atmosphere | 1.23 | 1.74 | 0.71 | 0.48 | -2.22, 4.67 | |
Spouse's attitude=Oppose | 10.24 | 11.9 | 0.86 | 0.39 | -22.65, 23.99 | |
Spouse's attitude=Neutral | -28.17 | 13.81 | -2.04 | 0.04 | -13.31, 33.79 | |
Family support | 13.89 | 7.08 | 1.96 | 0.05 | -55.5, -0.84 | |
HBV infected | -6.9 | 2.13 | -3.25 | 0.001 | -11.11, -2.7 | |
PCS (5-13 weeks postpartum) | Payment method=Public insurance | 10.27 | 7.18 | 1.43 | 0.16 | -3.94, 24.48 |
Payment method=Self-pay | -8.23 | 3.19 | -2.59 | 0.01 | -14.54, -1.93 | |
Other diseases before pregnancy | -7.97 | 3.12 | -2.56 | 0.01 | -14.15, -1.8 | |
HBV infected | -6.18 | 2.16 | -2.89 | 0.01 | -10.45, -1.92 |
Tab.5 Multivariate linear regression analysis of factors affecting the quality of life of the participants
Dimensions | Variables | β | Standard Error | t | P | 95% CI |
---|---|---|---|---|---|---|
MCS (32 weeks gestation-Delivery) | Working full time | -0.6 | 2.43 | -0.25 | 0.81 | -5.41, 4.21 |
HBV infected | -5.94 | 2.23 | -2.66 | 0.01 | -10.35, 1.53 | |
MCS (5-13 weeks postpartum) | Payment method=Public insurance | -6.43 | 6.91 | -0.93 | 0.35 | -20.11, 7.24 |
Payment method=Self-pay | -8 | 3.12 | -2.56 | 0.01 | -14.17, -1.82 | |
Family atmosphere | 1.23 | 1.74 | 0.71 | 0.48 | -2.22, 4.67 | |
Spouse's attitude=Oppose | 10.24 | 11.9 | 0.86 | 0.39 | -22.65, 23.99 | |
Spouse's attitude=Neutral | -28.17 | 13.81 | -2.04 | 0.04 | -13.31, 33.79 | |
Family support | 13.89 | 7.08 | 1.96 | 0.05 | -55.5, -0.84 | |
HBV infected | -6.9 | 2.13 | -3.25 | 0.001 | -11.11, -2.7 | |
PCS (5-13 weeks postpartum) | Payment method=Public insurance | 10.27 | 7.18 | 1.43 | 0.16 | -3.94, 24.48 |
Payment method=Self-pay | -8.23 | 3.19 | -2.59 | 0.01 | -14.54, -1.93 | |
Other diseases before pregnancy | -7.97 | 3.12 | -2.56 | 0.01 | -14.15, -1.8 | |
HBV infected | -6.18 | 2.16 | -2.89 | 0.01 | -10.45, -1.92 |
1 | Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance[J]. Hepatology, 2018, 67(4): 1560-99. |
2 | European Association for the Study of the Liver. EASL Clinical Practice Guidelines on the management of liver diseases in pregnancy[J]. J Hepatol, 2023, 79(3): 768-828. |
3 | Polaris Observatory Collaborators. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study[J]. Lancet Gastroenterol Hepatol, 2023, 8(10): 879-907. |
4 | Zhang SY, Wang FS, Zhang Z. Current advances in the elimination of hepatitis B in China by 2030[J]. Front Med, 2017, 11(4): 490-501. |
5 | Xin XN, Wang YY, Cheng J, et al. Seroepidemiological survey of hepatitis B virus infection among 764, 460 women of childbearing age in rural China: a cross-sectional study[J]. J Clin Virol, 2016, 81: 47-52. |
6 | Pan CQ, Duan ZP, Bhamidimarri KR, et al. An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus[J]. Clin Gastroenterol Hepatol, 2012, 10(5): 452-9. |
7 | 刘锦锋,曾庆磊, 纪泛扑. 中国乙型肝炎病毒母婴传播防治指南(2024年版)[J]. 临床肝胆病杂志, 2024, 40(08): 1557-66. |
8 | 尤 红, 庄 辉. 扩大慢性乙型肝炎抗病毒治疗的专家意见[J]. 中华肝脏病杂志, 2022, 30(2): 131-4. |
9 | Epstein RM, Street RL. The values and value of patient-centered care[J]. Ann Fam Med, 2011, 9(2): 100-3. |
10 | 李雁楠, 李镒冲, 张 梅, 等. 健康相关生命质量的研究进展[J]. 中华流行病学杂志, 2016, 37(9): 1311-7. |
11 | Li G, Wang G, Hsu FC, et al. Effects of depression, anxiety, stigma, and disclosure on health-related quality of life among chronic hepatitis B patients in Dalian, China[J]. Am J Trop Med Hyg, 2020, 102(5): 988-94. |
12 | Daida YG, Boscarino JA, Moorman AC, et al. Mental and physical health status among chronic hepatitis B patients[J]. Qual Life Res, 2020, 29(6): 1567-77. |
13 | Brekke M, Amro A, Småstuen MC, et al. Quality of life in Norwegian pregnant women and men with pregnant partners, and association with perception of sleep and depressive symptoms: a cross-sectional study[J]. BMC Pregnancy Childbirth, 2023, 23(1): 37. |
14 | Ishaq R, Shoaib M, Baloch NS, et al. Profile and predictors of maternal quality of life during physiological pregnancy: a cross-sectional analysis[J]. Front Public Health, 2021, 9: 801035. |
15 | Wu H, Sun W, Chen H, et al. Health-related quality of life in different trimesters during pregnancy[J]. Health Qual Life Outcomes, 2021, 19(1): 182. |
16 | 杨晓敏. 乙肝病毒感染孕妇生活质量及其相关因素研究[D]. 长沙: 中南大学, 2009. |
17 | 钟 钧, 杨舜英, 余双辉. 乙肝病毒感染孕妇心理健康状况与生活质量的调查分析[J]. 中国现代医生, 2010, 48(15): 94-5, 119. DOI: 10.3969/j.issn.1673-9701.2010.15.060 |
18 | 杨单单, 徐耀明, 赵建伟, 等. 简阳市乙型肝炎阳性孕妇生命质量评价及影响因素分析[J]. 中华疾病控制杂志, 2019, 23(3): 360-4. DOI: 10.16462/j.cnki.zhjbkz.2019.03.024 |
19 | Chen L, Yue P, Lamb KV, et al. Stigma in HBV-infected pregnant women in disclosed situations: Current status, influencing factors, and impacts on the quality of life[J]. Appl Nurs Res, 2020, 56: 151347. |
20 | OuYang S, Deng Y, Geng Y, et al. Patient-reported outcomes in mothers with chronic hepatitis B infection: a cross-sectional analysis[J]. Clin Res Hepatol Gastroenterol, 2025, 49(3): 102537. |
21 | 尤 红, 王福生, 李太生, 等. 慢性乙型肝炎防治指南(2022年版)[J]. 实用肝脏病杂志, 2023, 03(26): 457-78. |
22 | 中华医学会妇产科学分会产科学组, 中华医学会围产医学分会. 乙型肝炎病毒母婴传播预防临床指南(2020)[J]. 临床肝胆病杂志, 2020, 36(7): 1474-81. |
23 | 陈 峰. 医用多元统计分析方法[M]. 北京: 中国统计出版社, 2000. |
24 | Younossi ZM, Yu ML, Yilmaz Y, et al. Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™[J]. J Viral Hepat, 2023, 30(4): 335-44. |
25 | Zhou KN, Zhang M, Wu Q, et al. Reliability, validity and sensitivity of the Chinese (simple) short form 36 health survey version 2 (SF-36v2) in patients with chronic hepatitis B[J]. J Viral Hepat, 2013, 20(4): e47-55. |
26 | Godbole G, Irish D, Basarab M, et al. Management of hepatitis B in pregnant women and infants: a multicentre audit from four London hospitals[J]. BMC Pregnancy Childbirth, 2013, 13: 222. |
27 | Yin SM, Njai R, Barker L, et al. Summarizing health-related quality of life (HRQOL): development and testing of a one-factor model[J]. Popul Health Metr, 2016, 14(1): 22. |
28 | Fu MX, Lambert G, Cook A, et al. Quality of life in patients with HBV infection: a systematic review and meta-analysis[J]. JHEP Rep, 2025, 7(4): 101312. |
29 | Evon DM, Lin HS, Khalili M, et al. Patient-reported outcomes in a large North American cohort living with chronic hepatitis B virus: a cross-sectional analysis[J]. Aliment Pharmacol Ther, 2020, 51(4): 457-68. |
30 | 朱 萍, 赵志梅, 綦小蓉, 等. 晚孕期孕妇健康相关生命质量及其影响因素分析[J]. 中华妇幼临床医学杂志: 电子版, 2017, 13(4): 403-8. |
31 | Liu X, Wang S, Wang G. Prevalence and risk factors of postpartum depression in women: a systematic review and meta-analysis[J]. J Clin Nurs, 2022, 31(19/20): 2665-77. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||